Evaluate [ftcn]
adverse effects [ftcn]
CARDIOVASCULAR [bdsy]
Drug [phsu]
treatment [ftcn]
Benign [qlco]
prostatic hyperplasia [patf]
benign prostatic hyperplasia [patf]
methodology [inpr]
considerations [fndg]
Study [mnob]
effects [qlco]
Drug Exposure [fndg]
Diseases [dsyn]
Long [qlco]
Asymptomatic [fndg]
Clinical course [tmco]
Exposure NOS [inpo]
Classification [clas]
Biased [idcn]
Visible [qlco]
benign prostatic hyperplasia [patf]
Cardiovascular morbidity [dsyn]
Two Times [qnco]
Patients [podg]
Start [tmco]
Drug [phsu]
treatment [ftcn]
benign prostatic hyperplasia [patf]
Compared [acty]
Age [orga]
matched [resa]
Population Controls [ocdi]
CARDIOVASCULAR [bdsy]
Prognostic Factor [clna]
Exposed [clna]
Exposed [clna]
Validity [qnco]
randomized [resa]
Comparison [acty]
drug effects [ftcn]
treatment [ftcn]
strategies [menp]
Reporting [hlca]
Elderly [popg]
High Risk [qlco]
baseline [bodm]
experience [menp]
CARDIOVASCULAR [bdsy]
Events [evnt]
encounter [hlca]
methodology [inpr]
Problems [idcn]
Study [mnob]
adverse effects [ftcn]
CARDIOVASCULAR [bdsy]
Patients [podg]
benign prostatic hyperplasia [patf]
Products [enty]
randomized [resa]
Question [inpr]
Measure [qnco]
Database [inpr]
Relevant [qlco]
Prognostic Factor [clna]
Information [idcn]
Statistical [ocdi]
Adjustment [inbe]
Question [inpr]
Challenge [clna]
OBSERVATIONAL [resa]
Stress [fndg]
Need [qlco]
Biases [idcn]
choosing [acty]
Appropriate [qlco]
Study Design [resa]
Science [ocdi]
Reserve [acty]
